Document Detail


Factors influencing early results and complication rates of the thrombolytic treatment of lower limb ischemia with recombinant tissue-type plasminogen activator.
MedLine Citation:
PMID:  17069188     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
The aim of the study was to determine the effect of comorbidity conditions on the early outcome and complication rates of thrombolytic treatment of lower limb ischaemia with recombinant tissue plasminogen activator (rt-PA). Clinical and procedural data of 82 patients treated for acute/subacute arterial/graft occlusion were analysed retrospectively. Early results and adverse events were recorded and evaluated statistically. Early resolution of ischemic symptoms was achieved in 67 (82%) patients with a median dose of 25.4 mg of rt-PA. Major bleeding was reported in 9 and minor bleeding in 6 cases (intracranial hemorrhage rate 1%, mortality rate 1%, major amputation rate 1%). Comorbidity conditions and patient characteristics did not statistically influence success and complication rates. Bleeding was observed in patients who received a higher dose of the thrombolytic agent (30.0 mg vs 24.3 mg). Comorbidity conditions have no effect on early outcome and adverse events after thrombolytic management of lower limb ischemia. Higher doses of rt-PA with prolonged infusion times increase the risk of occurrence of treatment-related bleeding.
Authors:
Giuseppe Asciutto; Bruno Geier; Barbara Marpe; Thomas Hummel; Achim Mumme
Related Documents :
19128928 - What is the evidence on efficacy of spinal cord stimulation in (subgroups of) patients ...
8737708 - Acute and long-term effects of prostaglandin e1 assessed by clinical and microcirculato...
6239398 - Bypass versus primary major amputation in patients with femoropopliteal distal disease ...
16376208 - A prospective study of the fate of venous leg perforators after varicose vein surgery.
15540768 - Long-term followup of buccal mucosa onlay graft for hypospadias repair: analysis of com...
22810008 - Cruciate-retaining vs posterior-substituting inserts in total knee arthroplasty: functi...
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  Chirurgia italiana     Volume:  58     ISSN:  0009-4773     ISO Abbreviation:  Chir Ital     Publication Date:    2006 Sep-Oct
Date Detail:
Created Date:  2006-10-30     Completed Date:  2006-12-20     Revised Date:  2009-11-11    
Medline Journal Info:
Nlm Unique ID:  0151753     Medline TA:  Chir Ital     Country:  Italy    
Other Details:
Languages:  eng     Pagination:  597-604     Citation Subset:  IM    
Affiliation:
Klinik für Gefälsschirugie, St Josef Hospital, Klinikum der Ruhr Universität, Bochum, Germany.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Female
Fibrinolytic Agents / adverse effects,  therapeutic use*
Humans
Ischemia / drug therapy*
Lower Extremity / blood supply*
Male
Medical Records
Middle Aged
Retrospective Studies
Risk Factors
Thrombolytic Therapy / methods*
Tissue Plasminogen Activator / adverse effects,  therapeutic use*
Treatment Outcome
Chemical
Reg. No./Substance:
0/Fibrinolytic Agents; EC 3.4.21.68/Tissue Plasminogen Activator

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Sentinel lymph-node biopsy for breast cancer. Analysis of 235 cases and review of the literature
Next Document:  Incisional hernia at the trocar site in laparoscopic surgery